Salem, NHNCT06810518Now EnrollingIRB Ready

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) Clinical Trial in Salem, NH

Access cutting-edge inflammatory bowel disease (crohn's disease and ulcerative colitis) treatment through this clinical trial at a research site in Salem. Study-provided care at no cost to qualified participants.

Sponsored by American Laboratory Products Company

Quick Self-Assessment

See if you qualify for this Salem location

Preparing your pre-screening questions…

Expert Care in Salem

Access inflammatory bowel disease (crohn's disease and ulcerative colitis) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related inflammatory bowel disease (crohn's disease and ulcerative colitis) treatment provided free

Apply for This Salem Location

Check if you qualify for this inflammatory bowel disease (crohn's disease and ulcerative colitis) clinical trial in Salem, NH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Salem

    Convenient for NH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Salem site if eligible
  4. 4Begin participation

About This Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) Study in Salem

The ALPCO Calprotectin CLIA is an in vitro diagnostic test intended to quantitatively measure concentrations of fecal calprotectin in human stool samples. Calprotectin is a protein biomarker of mucosal inflammation. Measurement of calprotectin can aid in the diagnosis of Inflammatory Bowel Diseases (IBD), specifically Crohn's Disease (CD) and Ulcerative Colitis (UC), as well as aid in the differentiation of IBD from Irritable Bowel Syndrome (IBS) when used in conjunction with other diagnostic testing and the total clinical picture. The goal of the study is to generate data to support positive and negative predictive value of the ALPCO Calprotectin assay in patients with signs and symptoms of IBS or IBD.

Sponsor: American Laboratory Products Company

Who Can Participate

Inclusion Criteria

Male or female, ≥22 years of age (adults)
Suspected inflammatory bowel disease or irritable bowel syndrome with symptoms such as abdominal pain, diarrhea, altered appetite, weight loss, or anemia
Able to provide a sample according to the sampling protocol within 72-24 hours prior to the scheduled diagnostic endoscopy or 3-30 days after the colonoscopy.
Able to understand the study and the tasks required and sign the ICF

Exclusion Criteria

Unable or unwilling to provide a stool specimen
Known active intestinal cancer or in remission with abnormal levels (per physician assessment)
Known active intestinal infection or history of treated intestinal infection with persistent abnormal levels (per physician assessment)
IBD patients receiving chemotherapy or systemic immunosuppressive drugs without completing an 8-week washout period
IBD patients who have previously diagnosed IBD managed with immunomodulators, 5-ASA or biologic therapies without completing an 8-week washout period for biologics and immunomodulators or 4 weeks for 5-ASA
IBD patients who have previously been diagnosed with IBD and have undergone a surgical resection or diversion procedure.
Known upper Gl disease such as esophagitis or gastritis that might influence the study test's ability to detect intestinal inflammatory disease
Have taken NSAIDS (including aspirin) on 7 or more days during the 2 weeks before providing the sample
Samples are not collected according to sampling protocol.
Any condition that in the opinion of the investigator should preclude participation in the study. Using an IRB approved consent form, all study participants will be advised of study requirements and potential risks associated with study participation.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Salem?

Yes, this clinical trial (NCT06810518) has an active research site in Salem, NH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) Treatment Options in Salem, NH

If you're searching for inflammatory bowel disease (crohn's disease and ulcerative colitis) treatment options in Salem, NH, this clinical trial (NCT06810518) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Salem research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease (crohn's disease and ulcerative colitis) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all inflammatory bowel disease (crohn's disease and ulcerative colitis) clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Salem, NH

See all multiple myeloma clinical trials recruiting in Salem — not just this study.

Browse Multiple Myeloma Trials in Salem →

Browse More Trials by Condition

Multiple Myeloma TrialsFollicular Lymphoma TrialsRheumatoid Arthritis TrialsCrohns Disease TrialsUlcerative Colitis TrialsAnkylosing Spondylitis TrialsInflammatory Bowel Disease TrialsAll Conditions →

Ready to Join in Salem?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Salem, NH